Efficacy of sorafenib as adjuvant therapy to prevent early recurrence of hepatocellular carcinoma after curative surgery: A pilot study

Aim Until now, no effective adjuvant therapy to prevent early recurrence of hepatocellular carcinoma (HCC) after curative treatment has been reported. The aim of this study is to evaluate the clinical benefit of sorafenib as adjuvant treatment in subjects with HCC after hepatic resection. Methods Th...

Full description

Saved in:
Bibliographic Details
Published inHepatology research Vol. 44; no. 5; pp. 523 - 531
Main Authors Wang, Shen-Nien, Chuang, Shih-Cheng, Lee, King-Teh
Format Journal Article
LanguageEnglish
Published Netherlands Blackwell Publishing Ltd 01.05.2014
Subjects
Online AccessGet full text

Cover

Loading…